Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104
Condition:   Chronic Hepatitis b Interventions:   Drug: ISA104;   Drug: Placebo Sponsors:   Erasmus Medical Center;   ISA Pharmaceuticals B.V. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials